Complement C5

Complement C5

Complement C5 詳細

Molecule Name
Complement C5
分子の別称
Complement C5,C5,CPAMD4
Drug Development Progress
治験薬の数20
市販薬剤の数8
研究&開発段階Approved
ターゲットの別称
C5a,Complement Component 5,ECLZB,Anaphylatoxin C5a Analog,C5a Anaphylatoxin,C5b,C5,Prepro-C5,CPAMD4,Complement C5,C3 And PZP-Like Alpha-2-Macroglobulin Domain-Containing Protein 4,C5D
バックグランド
Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. C5 precursor is first processed by the removal of 4 basic residues, forming two chains, beta and alpha, linked by a disulfide bond. C5 convertase activates C5 by cleaving the alpha chain, releasing C5a anaphylatoxin and generating C5b (beta chain + alpha' chain). Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled. The C5a anaphylatoxin interacts with C5AR1 and tick complement inhibitor. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation.

Complement C5 製品リスト

Species
  • Human(6)
  • Cynomolgus(2)
  • Rat(2)
  • Mouse(1)
  • Rabbit(1)
Tag
  • His Tag(8)
  • His Tag & Avi Tag(3)
  • Fc Tag(1)
Host
  • HEK293(12)
Conjugate
  • Unconjugated(9)
  • Biotin-labeled(3)
Grade
  • RUO(12)
Low Endotoxin
  • Yes(1)
  • No(11)
You Have Viewed 1-10 Of 12 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Eculizumab biosimilar (CinnaGen)Phase 3 ClinicalCinnagen
Hemoglobinuria, Paroxysmal
詳細
Eculizumab biosimilar (IBC GENERIUM)Phase 3 ClinicalIbc Generium
Atypical Hemolytic Uremic Syndrome; Hemoglobinuria, Paroxysmal
詳細
Eculizumab biosimilar (Biocad)BCD-148Phase 3 ClinicalBIOCAD JSC
Hemoglobinuria, Paroxysmal
詳細
CemdisiranALN-CC5; AD-62643; ALN-62643; L96Phase 3 ClinicalAlnylam Pharmaceuticals Inc
Atypical Hemolytic Uremic Syndrome; Geographic Atrophy; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Macular Degeneration; Myasthenia Gravis; Myositis; Myositis, Inclusion Body
詳細
TesidolumabNOV-4; LFG-316Phase 2 ClinicalMorphosys Ag, Novartis Pharma Ag
Geographic Atrophy; Hemoglobinuria, Paroxysmal; Macular Degeneration; Panuveitis; Rejection of renal transplantation; Uveitis, Intermediate; Uveitis, Posterior; Wet Macular Degeneration
詳細
IM-101IM-101Phase 2 ClinicalImmunAbs Inc
Autoimmune Diseases; Myasthenia Gravis
詳細
ABBV-6628ABBV-6628Phase 2 ClinicalAbbvie Inc
Geographic Atrophy; Macular Degeneration
詳細
OCUL-101OCUL101Phase 2 ClinicalShenzhen Oukejian Biomedical Technology Co Ltd
Diabetic macular oedema; Geographic Atrophy; Macular Degeneration; Retinal Neovascularization
詳細
KRIYA-825KRIYA-825; VV-14295Phase 2 ClinicalKriya Therapeutics Inc
Geographic Atrophy
詳細
LP-005LP-005; RX-001Phase 2 ClinicalLongbio Pharma (Suzhou) Co Ltd
Amyotrophic Lateral Sclerosis; C3 glomerulopathy; Carcinoma, Non-Small-Cell Lung; Complement-Mediated Diseases; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Nephritis; Myasthenia Gravis; Periodontal Diseases; Peripheral Nervous System Diseases; Thrombotic Microangiopathies
詳細
Vensobafusp alfaP014; KP-104Phase 2 ClinicalKira Pharmaceuticals LLC
Glomerulonephritis; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Erythematosus, Systemic; Thrombotic Microangiopathies
詳細
OmoprubartCAN-106Phase 2 ClinicalBeihai Kangcheng (Beijing) Pharmaceutical Technology Co Ltd
Genetic Diseases, Inborn; Hemoglobinuria, Paroxysmal
詳細
ALXN-5500ALXN-5500Phase 1 ClinicalAlexion Pharmaceuticals Inc
Hemoglobinuria, Paroxysmal
詳細
RLYB-116RLYB-116Phase 1 ClinicalAffibody Ab, Swedish Orphan Biovitrum (Sobi)
Autoimmune Diseases; Hematologic Diseases; Immune System Diseases; Inflammation
詳細
SYH-2061SYH2061; SYH-2061Phase 1 ClinicalCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Complement-Mediated Diseases; Glomerulonephritis, IGA; Nephrosis
詳細
NM3086NM3086; NM-3086Phase 1 ClinicalNovelMed Therapeutics Inc
Hemoglobinuria, Paroxysmal
詳細
Eculizumab biosimilar (Turgut Ardika)TUR03; TUR-03Phase 1 ClinicalTurgut Ardika Pty Ltd
詳細
EA-5EA-5; EA5Phase 1 ClinicalShandong Lanyi Pharmaceutical Technology Co Ltd
Antiphospholipid Syndrome; Hemoglobinuria, Paroxysmal; Kidney Diseases; Myasthenia Gravis; Thrombotic Microangiopathies
詳細
RBD-7007RBD-7007Phase 1 ClinicalSuzhou Ribo Life Science Co Ltd
Glomerulonephritis, IGA
詳細
eculizumab biosimilar(Isu Abxis)ISU-305Phase 1 ClinicalIsu Abxis Co Ltd
Atypical Hemolytic Uremic Syndrome; Hemoglobinuria, Paroxysmal
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Avacincaptad pegol sodiumARC-1905; ARC-187ApprovedArchemix CorpZimura, IzervayUnited StatesMacular Degeneration; Geographic AtrophyIveric Bio Inc, Astellas Pharma Inc2023-08-04
Geographic Atrophy; Macular Degeneration; Polypoidal choroidal vasculopathy
詳細
Zilucoplan SodiumRA-101495-SC; RA-101495; ZLP-AIApprovedRa Pharmaceuticals Inc, Ucb SaZILBRYSQ, Zilbrysq, 卓倍可JapanMyasthenia GravisUcb Japan Co Ltd2023-09-25
Amyotrophic Lateral Sclerosis; Coronavirus Disease 2019 (COVID-19); Hemoglobinuria, Paroxysmal; Muscular Diseases; Myasthenia Gravis
詳細
CrovalimabRO-7112689/F01; SKY-59; RO711269; RO-711269; RG-6107; CH-7092230; RO-7092230; RO-7112689ApprovedChugai Pharmaceutical Co Ltd, F. Hoffmann-La Roche Ltd派圣凯, PiaskyMainland ChinaHemoglobinuria, ParoxysmalRoche Pharma (Schweiz) Ag, Roche (China) Holding Ltd, Genentech Inc2024-02-06
Anemia, Sickle Cell; Antiphospholipid Syndrome; Atypical Hemolytic Uremic Syndrome; Guillain-Barre Syndrome; Hemoglobinuria, Paroxysmal
詳細
RavulizumabALXN-1810; ALXN-1210ApprovedAlexion Pharmaceuticals Inc, Xencor IncUltomiris, 伟立瑞United StatesHemoglobinuria, ParoxysmalAlexion Pharmaceuticals Inc2018-12-21
Acute Kidney Injury; Acute Lung Injury; Amyotrophic Lateral Sclerosis; Atypical Hemolytic Uremic Syndrome; Coronavirus Disease 2019 (COVID-19); Delayed Graft Function; Dermatomyositis; Glomerulonephritis, IGA; Heart Diseases; Hemoglobinuria, Paroxysmal; Immunoglobulin A Vasculitis Associated Nephritis; Kidney Diseases; Kidney Failure, Chronic; Lupus Nephritis; Myasthenia Gravis; Neuromyelitis Optica; Pneumonia, Viral; Purpura, Schoenlein-Henoch; Rejection of renal transplantation; Renal Insufficiency, Chronic; Respiratory Distress Syndrome, Adult; Thrombotic Microangiopathies
詳細
EculizumabLEX-98; h-5G1.1; 5G1-1; HAL-1ApprovedAlexion Pharmaceuticals IncSoliris, 舒立瑞United StatesHemoglobinuria, ParoxysmalAlexion Pharmaceuticals Inc2007-03-16
Anemia, Hemolytic, Autoimmune; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome; Asthma; Atypical Hemolytic Uremic Syndrome; Delayed Graft Function; Diabetes Mellitus; End Stage Liver Disease; Glomerulonephritis, Membranoproliferative; Guillain-Barre Syndrome; HELLP Syndrome; Hemoglobinuria, Paroxysmal; Infant, Newborn, Diseases; Kidney Failure, Chronic; Macular Degeneration; Myasthenia Gravis; Nasopharyngeal Carcinoma; Neuromyelitis Optica; Parturition; Pre-Eclampsia; Rejection of renal transplantation; Rejection of organ transplantation; Thrombocytopenia; Urea Cycle Disorders, Inborn; Vagus Nerve Diseases
詳細
PozelimabREGN-3918ApprovedRegeneron Pharmaceuticals IncVEOPOZUnited StatesProtein-Losing EnteropathiesRegeneron Pharmaceuticals Inc2023-08-18
Geographic Atrophy; Hemoglobinuria, Paroxysmal; Myasthenia Gravis; Protein-Losing Enteropathies
詳細
Eculizumab biosimilar (Amgen)ABP-959ApprovedAmgen IncBKEMVUnited StatesHemoglobinuria, Paroxysmal; Atypical Hemolytic Uremic SyndromeAmgen Inc2024-05-28
Atypical Hemolytic Uremic Syndrome; Hemoglobinuria, Paroxysmal
詳細
Eculizumab biosimilar (Samsung Bioepis)SB-12; AM004; AMT-904; SB12ApprovedSamsung Bioepis Co LtdEpysqli, EPYSQLIEUAtypical Hemolytic Uremic Syndrome; Hemoglobinuria, ParoxysmalSamsung Bioepis Nl Bv2023-05-26
Atypical Hemolytic Uremic Syndrome; Hemoglobinuria, Paroxysmal
詳細
Customer Reviews
  • 1***32022-08-10
    I tried to express this product myself and it didn’t work, so I purchased ACRO’s products for antibody screening. The binding activity is very good and method establishment is also going very smoothly. There is also complete technical support available to help us solve any problems that arise during our experiments.